Does angiotensin-converting enzyme inhibitor and β-blocker use reduce the risk of primary liver cancer? A case-control study using the U.K. Clinical Practice Research Datalink

Journal: Pharmacotherapy Authors: Katrina Wilcox Hagberg, Vikrant V Sahasrabuddhe, Katherine A McGlynn, Susan S Jick NLM Citation: Hagberg KW, Sahasrabuddhe VV, McGlynn KA, Jick SS. Does angiotensin-converting enzyme inhibitor and β-blocker use reduce…